Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019; 21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Sara Scarlet, MD and Selwyn O. Rogers, Jr., MD, MPH
Pervasive and recurrent gun violence compels health care organizations to integrate violence prevention, intervention, and recidivism reduction as critical dimensions of good trauma care.
AMA J Ethics. 2018; 20(5):483-491. doi:
10.1001/journalofethics.2018.20.5.msoc2-1805.
The convening power of clinical ethics committees stems from their reputation for fairness and procedural legitimacy in addressing and resolving ethically complex cases.
AMA J Ethics. 2016; 18(5):540-545. doi:
10.1001/journalofethics.2016.18.5.msoc2-1605.
Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?